Objective: The WFS1 gene encodes an endoplasmic reticulum (ER) membrane-embedded protein.
Introduction
Wolfram syndrome is a rare recessively inherited genetic disorder, which is characteristically associated with juvenile onset diabetes mellitus and progressive optic atropy (1) . Sensorineural deafness, diabetes insipidus, ataxia, urinary-tract atony, peripheral neuropathy and psychiatric illness may also be present (2) . We and another group succeeded in cloning the gene responsible for this disorder and designated it WFS1 (3) or wolframin (4) . Loss-of-function mutations in the WFS1 gene have been linked to Wolfram syndrome. The WFS1 gene consists of eight exons coding for a putative 890 amino acid protein with an apparent molecular mass of , 100 kDa. WFS1 protein (wolframin) is a hydrophobic protein with nine transmembrane segments and large hydrophilic regions at both termini. WFS1 protein localizes primarily to the endoplasmic reticulum (ER) in a N cyt /C lum membrane topology (5, 6) . A recent report suggested that expression of WFS1 protein in oocytes was associated with an increase in cytosolic Ca 2þ and induced novel cation-selective channel activities in the ER membrane (7) . However, its role in cellular functions and the mechanism by which mutations of this gene cause Wolfram syndrome remain largely unknown.
ER is a specialized organella involved in a wide variety of cellular functions. Calcium regulation and post-translational modification, folding and trafficking of secreted and membrane integral proteins are well-defined ER functions (8) . Various physiological and pathological conditions interfere with these functions, and overloading of these functions induces ER stress. Cells respond to such stress by activating several adaptive pathways including chaperone induction, protein translation attenuation, and occasionally apoptosis, collectively called the unfolded protein response (9) . Characteristically, pancreatic b-cells have highly developed ER apparently due to the heavy demands of insulin biosynthesis and secretion. Beta-cells are highly susceptible to ER stress. Several studies have shown that b-cell mass is reduced in patients with type 2 diabetes, possibly due to apoptotic death of b-cells and to reduced cell proliferation (10) . ER stress may be involved in this process (11) . In the Akita mouse, an animal model of MODY (maturity onset diabetes of the young), which carries a conformation-altering missense mutation (Cys96Tyr) in the insulin-2 (Ins2) gene (12, 13) , hyperglycemia and reduced b-cell mass are accompanied by ER stressinduced b-cell death (14) . Based on the ER localization of WFS1 protein, it is reasonable to speculate that WFS1 protein may play an as yet undefined role in the ER stress-induced cell death of pancreatic b-cells. In fact, we showed islet cells lacking Wfs1 to be more susceptible to ER stress-induced apoptosis (15) , and, more recently, Yamaguchi et al. reported that treatment with ER stress inducers increased Wfs1 protein expression in isolated mouse pancreatic islets (16) .
In the present study, immunohistochemical staining confirmed b-cells to be the major site of Wfs1 expression in the mouse pancreas. Furthermore, this expression was also evident in d-cells but not in a-cells. The WFS1 gene was clearly expressed in response to drug-induced ER stress in both fibroblasts and pancreatic b-cell-derived MIN6 cells. Under the same conditions, the human WFS1 promoter luciferase reporter was activated suggesting transcriptional control of WFS1 expression. Furthermore, Wfs1 mRNA and protein levels were increased in Akita mouse-derived Ins2 96Y/Y insulinoma cells, in which the ER stress response had been triggered (17) . Our results demonstrate that not only druginduced but also intrinsic ER stress leads to WFS1 expression in pancreatic b-cells, and this occurs, at least in part, via transcriptional activation of the WFS1 promoter. These findings further suggest a functional link between WFS1 and ER stress responses.
Research design and methods
Tissue preparation and immunohistochemical staining of the mouse pancreas All experimental protocols for this study were approved by the committee on the Ethics of Animal Experimentation at Yamaguchi University School of Medicine. The anti-Wfs1 antibodies were described previously (5, 15) . Double immunofluorescent staining was performed for co-localization studies. Sections were pre-incubated, bleached (18) , and stained with a mixture of antiWfs1n (diluted 1:200) and mouse monoclonal antiinsulin (diluted 1:100; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-glucagon (diluted 1:200; Sigma-Aldrich, St Louis, MO, USA), or anti-somatostatin (diluted 1:25; Biomeda Corporation, Foster City, CA, USA) in 0.1 M sodium phosphate buffer containing 0.3% Triton X-100, 0.1% sodium azide, and 3% normal goat serum (PBT-NGS) for 24 h at 20 8C. Next, the sections were incubated with a mixture of two secondary antibodies in PBT-NGS for 24 h at 20 8C. The secondary antibodies used were Alexa Fluor 488 conjugated with goat anti-rabbit IgG (H þ L), highly cross absorbed (Molecular Probes, Eugene, OR, USA) and diluted 1:100, and an Alexa Fluor 594 conjugated to goat anti-mouse IgG (H þ L), F(ab')2 fragment (Molecular Probes), diluted 1:100. The sections were coverslipped with VECTASHIELD mounting medium (Vector Laboratories, Burlingame, CA, USA). As a control, one of the two primary antibodies, for example either antiWfs1n or anti-insulin, was removed to check for cross-reactivity. In these control experiments, other procedures were the same as for Wfs1/insulin double staining. No cross-reactivity was observed in these experiments (data not shown).
In the case of double immunostaining for Wfs1 and pancreatic polypeptide (PP) detection, a mixture of anti-Wfs1n (diluted 1:200) and anti-PP (diluted 1:200; Linco Research, St Charles, MO, USA) was used for the primary antibody reaction. In the secondary antibody reaction step, sections were incubated in a mixture of Alexa Fluor 488 conjugated with donkey anti-rabbit IgG (H þ L; Molecular Probes) diluted 1:100 and Alexa Fluor 594 conjugated to goat antiguinea pig IgG (H þ L), highly cross absorbed (Molecular Probes) and diluted 1:100 in PBT-NGS containing 3% normal donkey serum. Other procedures for Wfs1/PP double staining were the same as for Wfs1/insulin double staining.
Cell culture and reagents
The mouse insulinoma cell line, MIN6 (19) , was a gift from Dr Junichi Miyazaki, Osaka University, Japan. Insulinoma cells derived from the Akita mouse and from normal littermates, Ins2
96Y/Y cells and Ins2 WT/WT cells respectively, were described previously (17) . These cells were maintained in Dulbecco's modified Eagle's medium (DMEM) (Sigma) supplemented with 15% fetal calf serum in an atmosphere of 5% CO 2 at 37 8C. The genotype for the insulin-2 gene was confirmed by restriction fragment length polymorphism (RFLP), as previously described (12, 13) . Human skin fibroblasts (CCD-1059SK) were obtained from ATCC (Manassas, VA, USA). Thapsigargin, ionomycin, A23187, cyclopiazonic acid, 4-chloro-m-cresol, tunicamycin and brefeldin A were purchased from Sigma.
Northern blot analysis
Total RNA isolated using an ISOGEN kit (NIPPON GENE, Tokyo, Japan) was electrophoresed in 1% agarose formaldehyde gel and transferred to nylon filters (Hybond-N plus, Amersham Pharmacia Biotech). The filters were prehybridized and hybridized in a buffer containing 50% deionized formamide, 5 £ sodium chloride-sodium phosphate-EDTA buffer (750 mmol/l NaCl, 43.25 mmol/l NaH 2 PO 4 , 6.25 mmol/l EDTA), 2 £ Denhardt's solution (0.04% bovine serum albumin, 0.04% Ficoll, 0.04% polyvinylpyrrolidone), and 0.1% soduim dodecyl sulfate at 42 8C. The hybridization buffer contained a radio-labeled 3.0 kb fragment of mouse Wfs1 cDNA (GeneBank Accession No. BC046988). After a stringent wash with 0.2 £ sodium chloride-sodium citrate buffer (3.3 mmol/l Na-citrate, 3.3 mmol/l NaCl) and 0.1% SDS at 50 8C, autoradiographs were digitally scanned and quantified using FULA2000 (Fuji Film, Tokyo, Japan). The blots were stripped and re-proved with a 1122 bp fragment encompassing the entire coding region of the mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA. The cDNA probes were labeled with a random primer DNA labeling kit (Ready-To-Go DNA Labeling Beads, Amersham Pharmacia Biotech) using a-[ 
Immunoblotting analysis
Cells were lysed in 20 mmol/l Tris -HCl (pH 7.6), 0.5% Nonidet P-40, 250 mmol/l sodium chloride, 3 mmol/l EDTA, 3 mmol/l EGTA, 1 mmol/l phenylmethylsulfonyl fluoride, 2 mmol/l sodium orthovanadate, 20 mg/ml aprotinin, 1 mmol/l dithiothreitol and 5 mg/ml leupeptin. Proteins in cell lysates were separated in 10% SDS-PAGE gel and then electrophoretically transferred onto a nitrocellulose membrane. All membranes were stained with Ponceau S to confirm equal protein loading. The membrane was blocked with 5% milk in TBS-T (50 mmol/l Tris-HCl, 300 mmol/l NaCl, pH 7.6, 0.1% Tween 20) for 1 h. SDS-PAGE and immunoblotting were carried out as described previously (20) . Anti-Bip (GRP74), anti-Chop, anti-phosphorylated eIF2-a, and anti-poly(ADP-ribose) polymerase (PARP) antibodies were purchased from Santa Cruz Biotechnology. Detection was performed using the ECL system (Amersham Pharmacia Biotech).
Luciferase assay
To construct the WFS1 promoter-luciferase reporter gene, the promoter region of the human WFS1 gene (2 3000 to þ 20, Genbank Accession No. AC004689) was PCR-amplified from human genomic DNA. The fragment was inserted upstream from the luciferase cDNA in a pGL3-Basic vector (Promega, Madison, WI, USA). A plasmid, pCMVb (Clontech, Palo Alto, CA, USA), containing the cytomegalovirus (CMV) promoter-driven b-galactosidase gene was used as an internal control for the normalization of transfection efficiency. One day before transfection, MIN6 cells or Ins2 96Y/Y cells were plated at 1 £ 10 5 /well into 6-well tissue culture plates. The reporter plasmid (0.5 mg) and the pCMVb (0.5 mg) were co-transfected into MIN6 cells or Ins2
96Y/Y cells in 6-well tissue culture plates using 10 ml LipofectAMINE 2000 (Invitrogen) in serum-free Opti-MEM medium (Invitrogen). Twenty-four hours after transfection, the medium was changed to DMEM containing 15% fetal calf serum and 20 mmol/l glucose, and cultured for a further 24 h. After this 24-h incubation, MIN6 cells were treated with thapsigargin or tunicamycin for an additional 6 h. Cell extracts were prepared, and luciferase and b-galactosidase activities were determined using a b-galactosidase enzyme assay system according to the manufacturer's protocol (Promega).
Results

Wfs1 expression in the mouse pancreatic islet
Using immunohistochemistry, it was demonstrated that mouse Wfs1 protein was widely expressed in pancreatic islets except in some peripheral areas, while no signals for Wfs1 protein were detected in exocrine acinar cells (Figs 1 and 2 and data not shown). Using double-immunofluorescent staining, the majority of Wfs1-immunoreactive cells were found to coincide with insulin-producing b-cells. Some minor part of the Wfs1 immunoreactivity was, however, localized to non-b-cells seen in the islet periphery (Fig. 1A -F) . Such Wfs1-immunoreactive non-b-cells were found to correspond to somatostatin-producing d-cells (Fig. 1G -L) . There was little difference in Wfs1-immunoreactive intensity between the two endocrine cell types (Fig. 1 ). Wfs1-immunoreactivity was not evident in glucagon-producing a-cells or in pancreatic polypeptide cells (PP-cells; Fig. 2 ).
ER stress induces WFS1 expression in fibroblasts
ER stress induces cellular responses, collectively termed the unfolded protein response, affecting diverse areas of cellular function such as gene expression, metabolism, cell signaling and apoptosis. Certain reagents are known to disturb ER calcium homeostasis or to inhibit post-translational processing or sorting, and thereby to cause ER stress (9) . Chemical insults inducing ER stress, the calcium ionophor A23187 and ionomycin, the ER Ca 2þ -ATPase inhibitors (21) thapsigargin and cyclopiazonic acid, the ryanodine receptor activator 4-chloro-m-cresol, and the protein N-glycosylation inhibitor tunicamycin all induced WFS1 protein as shown in Fig. 3 . Only brefeldin A had no effect. Ionomycin only weakly induced WFS1 protein. The differing effects of these chemicals, which have different mechanisms of action, may provide insights into the functions of Wfs1. The lack of WFS1 induction with brefeldin A, a Golgi apparatus disruptor, may be related to its instability in solution (22) . Although we did not perform Northern blot analysis for each of these reagents, A23187 induced WFS1 mRNA in fibroblasts (data not shown).
Effects of thapsigargin and tunicamycin on Wfs1 expression in MIN6 cells
We next examined the effects of thapsigargin and tunicamycin on the expression of Wfs1 mRNA in MIN6 cells. Thapsigargin and tunicamycin treatments are known to induce ER stress, and Chop/GADD153 is a transcription factor that plays a role in ER stress-induced apoptotic cell death (23, 24) . Phosphorylation of the a-subunit of translation initiation factor-2 (eIF2-a) attenuates protein translation upon ER stress. Although the ER chaperone Bip/GRP78 expression did not change in MIN6 cells (Fig. 4B ) probably due to its strong basal expression, thapsigargin and tunicamycin clearly generated ER stress as demonstrated by Chop induction and eIF2-a phosphorylation (Fig. 4A, B) . Under these conditions, ER stress-induced caspase-3 activation, an event at the initiation of apoptosis (25) , was evidenced by the cleavage of PARP (Fig. 4C) . PARP is one of the substrates cleaved by caspase-3. Upon thapsigargin or tunicamycin treatment, the 113 kDa band decreased, and instead, the proteolytic PARP fragment (89 kDa) appeared (Fig. 4C) . In association with ER stress induction and caspase-3 activation, Wfs1 mRNA expression increased (Fig.  4A,D) . With thapsigargin, Wfs1 mRNA started to increase after 6 h and was maximal after 12 h. With tunicamycin, Wfs1 mRNA induction peaked at 6 h, and then declined. Wfs1 protein was also increased by thapsigargin treatment (Fig. 4B) . In contrast, tunicamycin, despite the mRNA induction, did not increase the Wfs1 protein, but decreased it after 24 h (Fig. 4B) . This is probably due to the instability of unglycosylated Wfs1 protein (6, 16).
Thapsigargin and tunicamycin enhance human WFS1 promoter activity in MIN6 cells
To determine the mechanism of WFS1 expression, we examined the effects of thapsigargin and tunicamycin on human WFS1 gene promoter activity by employing transient transfection assays in MIN6 cells. We used a WFS1 promoter-luciferase construct that contained a 3 kb DNA sequence upstream from the human WFS1 gene transcription initiation site. The human WFS1 gene promoter was active in MIN6 cells. Introduction of the WFS1 promoter-reporter plasmid produced a 20-fold increase in luciferase activity as compared with the promoterless pGL3-Basic vector. Treatment of the cells with thapsigargin or tunicamycin resulted in further 1.3-and 1.5-fold increases in luciferase activity respectively (Fig. 5) . We conducted these experiments again using a 1 kb (2 1000 to þ 20) WFS1 promoter-luciferase reporter gene. The results were essentially the same but the promoter activity was weaker than with the 3 kb construct (data not shown). 
Wfs1 expression is transcriptionally upregulated in b-cells with intrinsic ER stress
In the Akita mouse, the C96Y mutation of the ins2 gene disturbs intramolecular disulfide bond formation, resulting in progressive b-cell loss (12) . ER stress and subsequent apoptosis are at least partially responsible for this progressive b-cell loss (14) . To further examine the association between increased Wfs1 expression and ER stress, we used mouse insulinoma cells derived from an Akita mouse homozygous for the ins2 gene C96Y mutation (Ins2 96Y/Y cell) as a model. Ins2 WT/WT cells derived from normal littermates served as controls. Doubling of the ER chaperone Bip/GRP78 in Ins2 96Y/Y cells indicated persistent ER stress in these cells (Fig. 6A) . In Ins2 96Y/Y cells, Wfs1 protein increased sixfold as compared with that in Ins2 WT/WT cells (Fig. 6B ). Wfs1 mRNA expression was also increased twofold (data not shown). We next examined WFS1 promoter activity in these cells. Introduction of the WFS1 promoter-reporter plasmid into Ins2 96Y/Y cells approximately doubled luciferase activity as compared with that in wild type Ins2
WT/WT cells (Fig. 7) . Luciferase activity after transfection of the SV40 promoter-reporter plasmid did not differ between Ins2 96Y/Y and Ins2 WT/WT cells.
Discussion
Herein, we have documented the localization of Wfs1 expression in the mouse pancreatic islet. Insulin-producing b-cells are the major site of Wfs1 expression, as shown in Ishihara et al. (15) . Wfs1 expression is also evident in somatostatin-producing d-cells, but is absent from glucagon producing a-cells and PP-cells. No Wfs1 expression is observed in pancreatic exocrine acinar Figure 4 Thapsigargin and tunicamycin increase Wfs1 mRNA expression in MIN6 cells in association with ER stress and apoptosis induction. MIN6 cells were placed in culture dishes and serumstarved in serum-free DMEM for 12 h, and then treated with thapsigargin (1 mmol/l) or tunicamycin (10 mg/ml) for 6, 12 or 24 h. Dimethyl sulfoxide (DMSO) was used to dissolve thapsigargin and tunicamycin, and the same concentration of DMSO (final, 0.05%) was employed in all experiments, including controls. After incubation, cells were washed once with ice-cold phosphate-buffered saline, and harvested. (A) Ten micrograms RNA were subjected to Northern blot analysis. (B) Total cell lysates containing equal amounts of protein (50 mg) were separated on 10% SDS-PAGE and analyzed by immunoblotting using anti-Wfs1n, anti-Bip (GRP74), anti-Chop or anti-phosphorylated eIF2-a, (C) Total cell lysates containing equal amounts of protein (50 mg) were separated on 10% SDS-PAGE and analyzed by immunoblotting using the anti-PARP antibody. Activated caspase-3 cleaves the 113 kDa PARP, resulting in the appearance of the 89 kDa fragment.
(D) Quantification of the Wfs1 mRNA from the results obtained in (A), shown as means^S.E. (n ¼ 4). Statistical analysis, conducted using analysis of variance, indicated that the thapsigargin and tunicamycin treatments significantly increased Wfs1 mRNA expression at 12 h and at 6 h and 12 h respectively (*P , 0.05, **P , 0.001). 
cells. A histopathological study of pancreatic islets from
Wolfram syndrome patients showed selective loss of insulin-producing b-cells and an apparent preservation of glucagon-producing a-, somatostatin-producing d-, and PP-cells (26, 27) . The histochemical evidence of Wfs1 protein localization in insulin-producing b-cells might provide a histological background explaining the insulin deficiency caused by WFS1 mutations in Wolfram syndrome patients and suggests that WFS1 protein is necessary for b-cell (28, 29), but not d-cell survival. We have also presented evidence herein that ER stress induces Wfs1 gene expression. Treatment of fibroblasts with A23187, ionomycin, thapsigargin, cyclopiazonic acid, 4-chloro-m-cresol or tunicamycin increased Wfs1 protein levels. Chemical insults by these reagents are known to induce ER stress via disruption of Ca 2þ homeostasis or inhibition of N-linked glycosylation. Thapsigargin and tunicamycin treatments also induced Wfs1 mRNA expression in a mouse b-cell line, MIN6 cells. In accordance with the mRNA change, thapsigargin increased Wfs1 protein expression. However, the Wfs1 protein level in MIN6 cells did not change with tunicamycin. This is probably due to Wfs1 being an N-glycosylated protein, and inhibition of glycosylation by tunicamycin decreases its stability (6, 16) . Increased Wfs1 expression in association with ER stress was further demonstrated in another b-cell model with ER stress: Ins2 96Y/Y cells derived from the Akita mouse. The Akita mouse spontaneously develops early-onset non-obese diabetes with a reduced b-cell mass, which is caused by a conformation-altering missense mutation (Cys96Tyr) in the insulin-2 gene (12, 13) . Intramolecular disulfide-bond formation is disrupted in the mutant insulin molecule. It was reported that this misfolded mutant insulin expression constitutively induced ER stress in Akita mouse b-cells (14 (Fig. 6) were both increased. The increased Wfs1 mRNA (twofold, data not shown) was consistent with the increased Wfs1 promoter activity (Fig. 7) CCAAT-N9-CCACG (30) . The general transcriptional factor, NF-Y/CBF, binds to the CCAAT motif of the ERSE (31) . Once ER stress ensues, p50ATF6 (active form of transcriptional factor ATF6) binds to the CCACG motif of the ERSE (31, 32) resulting in transcriptional induction of ER chaperones. Another ERSE (ERSE-II) with a consensus sequence of ATTGG-N-CCACG has also been identified (32) . Although there are six CCAAT motifs in the 2 2800 to 2 2300 region of the putative human WFS1 promoter, we found no ERSE consensus sequences within 3 kb upstream from the transcription initiation site. Further studies will be required to elucidate the mechanism of transcriptional regulation of the Wfs1 gene via ER stress.
The observations made in this study suggest that Wfs1 protein may be involved in the ER stress response pathway, i.e. the unfolded protein response, in which cells respond by inducing chaperones, attenuating protein translation, and inducing apoptosis. Pancreatic b-cells suffer under chronic ER stress, striving to meet the increasing demands of insulin biosynthesis and secretion. In patients with Wolfram syndrome (26) and in Wfs1 knock-out mice (15) , b-cells were selectively lost from pancreatic islets. Moreover, islets from Wfs 2/2 mice were highly susceptible to ER stress (thapsigargin and tunicamycin)-induced apoptosis (15) . It is tempting to speculate that Wfs1 protein is upregulated in response to ER stress and that it plays a physiological role in protecting cells from ER stressinduced apoptosis. Loss of function mutations of the Wfs1 gene may cause b-cell loss due to disruption of this protective function. It was recently reported that Wfs1 protein expressed in oocytes exhibited a cationselective ion channel activity (7) . Expression of Wfs1 protein in oocytes increased cytosolic Ca 2þ levels (7), and islets from Wfs1 2/2 mice exhibited attenuated glucose-stimulated intracellular Ca 2þ responses (15 
